Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


06.03.2017

9 AIDS
1 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
5 Antivir Ther
1 BMC Pediatr
2 HIV Med
1 Int J Dermatol
4 J Acquir Immune Defic Syndr
2 J Med Virol
1 J Pediatr
7 J Virol
2 JAMA
2 Lancet HIV
1 Lancet Infect Dis
1 Pediatrics
1 PLoS Med
11 PLoS One
4 PLoS Pathog
1 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. TORIBIO M, Fitch KV, Sanchez L, Burdo TH, et al
    Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in intrepid: a randomized trial in HIV.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001427.
    PubMed     Text format     Abstract available

  2. VESA J, Chaillon A, Wagner GA, Anderson CM, et al
    Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001445.
    PubMed     Text format     Abstract available

  3. BRYANT AK, Moore DJ, Burdo TH, Lakritz JR, et al
    Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001425.
    PubMed     Text format     Abstract available

  4. BENGTSON AM, Pence BW, Moore R, Mimiaga MJ, et al
    The relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001431.
    PubMed     Text format     Abstract available

  5. MAHEU-GIROUX M, Tanser F, Boily MC, Pillay D, et al
    Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001435.
    PubMed     Text format     Abstract available

  6. KIRKEGAARD-KLITBO DM, Mejer N, Knudsen TB, Moller HJ, et al
    Soluble CD163 Predicts Incident Chronic Lung, Kidney and Liver Disease in HIV Infection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001432.
    PubMed     Text format     Abstract available

  7. MARCUS JL, Leyden WA, Chao CR, Horberg MA, et al
    Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001434.
    PubMed     Text format     Abstract available

  8. BURGOS J, Curran A, Landolfi S, Guelar A, et al
    Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected men who have sex with men.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001433.
    PubMed     Text format     Abstract available

  9. TOBIN SC
    Evaluating the generalizability of clinical trials of direct-acting antivirals for HIV/HCV-coinfection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001439.
    PubMed     Text format    


    AIDS Res Hum Retroviruses

  10. KOSS CA, Bacchetti P, Hillier SL, Livant E, et al
    Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.
    AIDS Res Hum Retroviruses. 2017 Mar 2. doi: 10.1089/aid.2016.0202.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  11. NIGO M, Diaz L, Carvajal LP, Tran TT, et al
    Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


    Antivir Ther

  12. BOESECKE C, Singh GK, Scholten SH, Lutz T, et al
    Telaprevir-containing triple therapy in acute HCV coinfection: The CHAT Study.
    Antivir Ther. 2017 Feb 27. doi: 10.3851/IMP3143.
    PubMed     Text format     Abstract available

  13. BHAGWAT P, Ofotokun I, McComsey GA, Brown TT, et al
    Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes.
    Antivir Ther. 2017 Mar 1. doi: 10.3851/IMP3148.
    PubMed     Text format     Abstract available

  14. BISSIO E, Barbas MG, Kademian S, Bouzas MB, et al
    Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina.
    Antivir Ther. 2017 Feb 24. doi: 10.3851/IMP3147.
    PubMed     Text format     Abstract available

  15. ARENAS-PINTO A, Stohr W, Clarke A, Williams I, et al
    Evaluation of CSF virological escape in patients on long-term PI monotherapy.
    Antivir Ther. 2017 Feb 24. doi: 10.3851/IMP3146.
    PubMed     Text format     Abstract available

  16. TRAN M, Wood E, Kerr T, Patterson S, et al
    Increases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada.
    Antivir Ther. 2017 Feb 24. doi: 10.3851/IMP3145.
    PubMed     Text format     Abstract available


    BMC Pediatr

  17. MORALEDA C, Aguilar R, Quinto L, Nhampossa T, et al
    Anaemia in hospitalised preschool children from a rural area in Mozambique: a case control study in search for aetiological agents.
    BMC Pediatr. 2017;17:63.
    PubMed     Text format     Abstract available


    HIV Med

  18. GEBRESELASSIE HM, Kraus D, Fux CA, Haubitz S, et al
    Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12491.
    PubMed     Text format     Abstract available

  19. PAYNE B, Chadwick TJ, Blamire A, Anderson KN, et al
    Does efavirenz replacement improve neurological function in treated HIV infection?
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12503.
    PubMed     Text format     Abstract available


    Int J Dermatol

  20. SANCHEZ-MORENO EC, Marioni-Manriquez S, Fernandez-Martinez RF, Moreno-Coutino G, et al
    Accelerated nail growth rate in HIV patients.
    Int J Dermatol. 2017 Feb 23. doi: 10.1111/ijd.13498.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  21. RAY N, Li T, Lin Z, Protack T, et al
    The second-generation maturation inhibitor GSK3532795 maintains potent activity toward HIV protease inhibitor-resistant clinical isolates.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001304.
    PubMed     Text format     Abstract available

  22. MUSARANDEGA R, Machekano R, Chideme M, Muchuchuti C, et al
    PMTCT Service Uptake among Adolescents and Adult Women Attending Antenatal Care in Selected Health Facilities in Zimbabwe.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001327.
    PubMed     Text format     Abstract available

  23. HERNANDEZ S, Catalan-Garcia M, Moren C, Garcia-Otero L, et al
    Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis And Adverse Perinatal Outcomes In Hiv-Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001334.
    PubMed     Text format     Abstract available

  24. CARLUCCI JG, Blevins M, Kipp AM, Lindegren ML, et al
    Tuberculosis Treatment Outcomes among HIV/TB Co-Infected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001335.
    PubMed     Text format     Abstract available


    J Med Virol

  25. LIU Z, Fang Q, Zhou S, Minhas V, et al
    Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.
    J Med Virol. 2017 Mar 2. doi: 10.1002/jmv.24804.
    PubMed     Text format     Abstract available

  26. AUGUSTO A, Augusto O, Taquimo A, Nhachigule C, et al
    First description of HTLV-1/2 seroprevalence in HIV-infected inmates in Mozambique.
    J Med Virol. 2017 Feb 27. doi: 10.1002/jmv.24801.
    PubMed     Text format     Abstract available


    J Pediatr

  27. RAWIZZA H
    Triple-drug antiretroviral therapy results in lower HIV maternal-fetal transmission rates but increased adverse effects compared with zidovudine alone.
    J Pediatr. 2017;182:401-404.
    PubMed     Text format    


    J Virol

  28. STULTZ RD, Cenker JJ, McDonald D
    Imaging HIV-1 Genomic DNA from Entry through Productive Infection.
    J Virol. 2017 Mar 1. pii: JVI.00034-17. doi: 10.1128/JVI.00034.
    PubMed     Text format     Abstract available

  29. YU FH, Huang KJ, Wang CT
    C-terminal HIV-1 transframe p6* tetra-peptide blocks enhanced Gag cleavage incurred by leucine zipper replacement of a deleted p6* domain.
    J Virol. 2017 Mar 1. pii: JVI.00103-17. doi: 10.1128/JVI.00103.
    PubMed     Text format     Abstract available

  30. KENNEDY EM, Courtney DG, Tsai K, Cullen BR, et al
    Viral Epitranscriptomics.
    J Virol. 2017 Mar 1. pii: JVI.02263-16. doi: 10.1128/JVI.02263.
    PubMed     Text format     Abstract available

  31. SMITH SA, Derdeyn CA
    New connections: Cell to cell HIV-1 transmission, resistance to broadly neutralizing antibodies, and an envelope sorting motif.
    J Virol. 2017 Mar 1. pii: JVI.00149-17. doi: 10.1128/JVI.00149.
    PubMed     Text format     Abstract available

  32. OPAZO T, Garces A, Tapia D, Barraza F, et al
    Functional evidence of the involvement of the dynein light chain DYNLRB2 in murine leukemia virus infection.
    J Virol. 2017 Mar 1. pii: JVI.00129-17. doi: 10.1128/JVI.00129.
    PubMed     Text format     Abstract available

  33. LIU Y, Pan J, Cai Y, Grigorieff N, et al
    Conformational states of a soluble, uncleaved HIV-1 envelope trimer.
    J Virol. 2017 Mar 1. pii: JVI.00175-17. doi: 10.1128/JVI.00175.
    PubMed     Text format     Abstract available

  34. HUANG J, Zhu L, Qiu C, Xu X, et al
    MiR-126-5p enhances the inflammatory responses of monocytes to LPS stimulation by suppressing CYLD in chronic HIV-1 infection.
    J Virol. 2017 Mar 1. pii: JVI.02048-16. doi: 10.1128/JVI.02048.
    PubMed     Text format     Abstract available


    JAMA

  35. FRIEDRICH MJ
    Uneven Progress in Preventing and Treating HIV Infections Worldwide.
    JAMA. 2017;317:687.
    PubMed     Text format    

  36. ZYLKE JW
    Coping With Uncertainty: Roz, Ray, and the AIDS Epidemic.
    JAMA. 2017;317:116-117.
    PubMed     Text format    


    Lancet HIV

  37. KIMMEL AD, Nash D
    HIV prevention resources: time to move toward affordability.
    Lancet HIV. 2017 Feb 20. pii: S2352-3018(17)30022.
    PubMed     Text format    

  38. CREMIN I, McKinnon L, Kimani J, Cherutich P, et al
    PrEP for key populations in combination HIV prevention in Narobi: a mathematical modelling study.
    Lancet HIV. 2017 Feb 20. pii: S2352-3018(17)30021.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  39. KECHICHIAN E, Tomb R
    Widespread borderline tuberculoid leprosy with HIV co-infection.
    Lancet Infect Dis. 2017;17:348.
    PubMed     Text format    


    Pediatrics

  40. CHANDER P, Kvalsvig J, Mellins CA, Kauchali S, et al
    Intimate Partner Violence and Child Behavioral Problems in South Africa.
    Pediatrics. 2017;139.
    PubMed     Text format     Abstract available


    PLoS Med

  41. BEKKER LG, Gray GE
    Hope for HIV control in southern Africa: The continued quest for a vaccine.
    PLoS Med. 2017;14:e1002241.
    PubMed     Text format     Abstract available


    PLoS One

  42. HARDY L, Jespers V, Van den Bulck M, Buyze J, et al
    The presence of the putative Gardnerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis biofilm.
    PLoS One. 2017;12:e0172522.
    PubMed     Text format     Abstract available

  43. KIMARO GD, Mfinanga S, Simms V, Kivuyo S, et al
    The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    PLoS One. 2017;12:e0171917.
    PubMed     Text format     Abstract available

  44. MINCHELLA PA, Chipungu G, Kim AA, Sarr A, et al
    Specimen origin, type and testing laboratory are linked to longer turnaround times for HIV viral load testing in Malawi.
    PLoS One. 2017;12:e0173009.
    PubMed     Text format     Abstract available

  45. KIMULWO MJ, Okendo J, Aman RA, Ogutu BR, et al
    Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure.
    PLoS One. 2017;12:e0172960.
    PubMed     Text format     Abstract available

  46. MOSEPELE M, Hemphill LC, Palai T, Nkele I, et al
    Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    PLoS One. 2017;12:e0172897.
    PubMed     Text format     Abstract available

  47. SCARPELLINI B, Zanoni M, Sucupira MC, Truong HM, et al
    Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.
    PLoS One. 2017;12:e0173164.
    PubMed     Text format     Abstract available

  48. DRECHSLER H, Ayers C, Cutrell J, Maalouf N, et al
    Current use of statins reduces risk of HIV rebound on suppressive HAART.
    PLoS One. 2017;12:e0172175.
    PubMed     Text format     Abstract available

  49. JUGA AJ, Hens N, Osman N, Aerts M, et al
    A flexible method to model HIV serodiscordance among couples in Mozambique.
    PLoS One. 2017;12:e0172959.
    PubMed     Text format     Abstract available

  50. CORLEIS B, Lisanti AC, Korner C, Schiff AE, et al
    Early type I Interferon response induces upregulation of human beta-defensin 1 during acute HIV-1 infection.
    PLoS One. 2017;12:e0173161.
    PubMed     Text format     Abstract available

  51. VERDIER T, Gunzenhauser J, Manley S, Castelnovo M, et al
    Single particle maximum likelihood reconstruction from superresolution microscopy images.
    PLoS One. 2017;12:e0172943.
    PubMed     Text format     Abstract available

  52. PARCZEWSKI M, Leszczyszyn-Pynka M, Witak-Jedra M, Szetela B, et al
    Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland.
    PLoS One. 2017;12:e0172473.
    PubMed     Text format     Abstract available


    PLoS Pathog

  53. MAIDJI E, Somsouk M, Rivera JM, Hunt PW, et al
    Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction.
    PLoS Pathog. 2017;13:e1006202.
    PubMed     Text format     Abstract available

  54. YODER AC, Guo K, Dillon SM, Phang T, et al
    The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria.
    PLoS Pathog. 2017;13:e1006226.
    PubMed     Text format     Abstract available

  55. YASEN A, Herrera R, Rosbe K, Lien K, et al
    Release of HIV-1 sequestered in the vesicles of oral and genital mucosal epithelial cells by epithelial-lymphocyte interaction.
    PLoS Pathog. 2017;13:e1006247.
    PubMed     Text format     Abstract available

  56. EASTERHOFF D, Moody MA, Fera D, Cheng H, et al
    Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
    PLoS Pathog. 2017;13:e1006182.
    PubMed     Text format     Abstract available


    Vaccine

  57. LEVIN MJ, Huang S, Moscicki AB, Song LY, et al
    Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
    Vaccine. 2017 Feb 23. pii: S0264-410X(17)30215.
    PubMed     Text format     Abstract available


    Virology

  58. BANERJEE S, Shi H, Banasik M, Moon H, et al
    Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Virology. 2017;505:113-126.
    PubMed     Text format     Abstract available

  59. BONAR MM, Tilton JC
    High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.
    Virology. 2017;505:80-90.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: